Exam #2 Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What does SNR stand for?

A

Substantia nigra pars reticulata-works with GPi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What does SNc stand for?

A

Substantia nigra pars compacta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does STN stand for?

A

Sub thalamic nucleus-modulator of basal ganglia output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Apoptosis

A

Programmed cell death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What can the Wt protein do that the mutant protein (expanded form) can’t do?

A

Prevent apoptosis, prevent excitotoxicity, regulate gene transcription, axonal transport, mitochondrial health

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why is there more apoptosis in mutant protein?

A

More PolyQ, leads to more caspase-9= “excecutioners”, expanded cells more susceptible to apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Autophagy

A

Process of aberrant (not normal) organelles breakdown inside autolysosome (isolation membrane–>autophagosome–>lysosome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mitophagy

A

Breakdown of mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens if lysosomal autophagy is disrupted?

A

Dysfunction and deregulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Aggregation

A

Formation of a number of things that form a cluster

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Aggregation in HD

A

Caspase-6 site-generates N-terminal fragments (PolyQ) that aggregate in cytoplasm and nucleus (GAIN OF FUNCTION), intracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Aggregation in AD

A

Amyloid forms aggregates extracellularly–> amyloid plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Aggregation in PD (4)

A
  • Alpha-syn. (found in Lewy bodies) forms aggregates
  • WT, A30P, & A53T form lipid-based aggregates
  • Dysfunction of ubiquitin proteasome system and lysosomal autophagy leads to failure to remove aggregates
  • Beta sheets are bad: sticky–>aggregates
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Excitotoxicity

A

Process by which nerve cells are damaged or killed by excessive stimulation by NTs, such as glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does excitotoxicity lead to?

A

Depolarized cell: impaired mitochondrial membrane potential–> more Calcium–> reduced ATP/ADT ration and increased NMDA currents (mimics glutamate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Excitotoxicity in AD

A

Amyloid beta (plaques) activate astrocytes and microglia–> secretion of toxic cytokines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does normal Whtt protein protect against apoptosis and caspase activation?

A
  • BCL2 is protective of mitochondria from apoptosis
  • Does not have more caspase-9 like mutant htt
  • Not as susceptible to NMDA toxicity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Symptoms of HD and why

A

Chorea (violent jerking movements) because of the disease favoring direct pathway. Indirect pathway neurons are most affected, which usually prevents unwanted movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Symptoms of AD and why

A

Decline in memory because of loss of cortex and hippocampus (large pyramidal cells most vulnerable), neuronal death (apoptosis, excitotoxicity, mitochondrial dysfunction, calcium dynamics, inflammation), plaques and tangles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Symptoms of PD and why

A

Resting tremor, rigidity, bradykinesia (slowed movement) or akinesia (lack of movement), postural instability because of loss of DA and SN neurons, DA deficiency in striatum
-Favors indirect pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Mixed diseases (2)

A

Dementia with Lewy bodies and HD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What causes plaques in AD?

A

Aggregation of Amyloid Beta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What causes tangles in AD?

A

Taupathy: binds well to itself, rather than microtubules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What causes tangles in AD?

A

Taupathy: binds well to itself, rather than microtubules

-Hyperphosphorylation of Tau

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Genetic causes of HD

A

Autosomal dominant, 50/50 chance, caused by mutation in Htt gene, >37 CAG repeats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Genetic causes of AD

A

Autosomal dominant,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Genetic causes of AD

A

Idiopathic (arises from itself), only 5% genetic, APOE4 allele is a risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What 3 genes do autosomal dominant genes express in AD?

A
  1. APP
  2. Presenilin 1
  3. Presenilin 2
    (2&3 make up gamma secretase)
    All affect amount of Ab42
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Genetic causes of PD

A

Alpha-syn. mutation or overexpression, DJ-1, Parkin, PINK-1, LRRK-2
-mutation on chromosome 4 at SCNA gene that codes for alpha-syn.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Environmental causes/risks in HD

A

Environment has no role in creating or decreases risk, genotype=phenotype in HD

31
Q

Environmental causes/risks in AD

A

None specifically mentioned, higher education level and more exercise could be protective factor

32
Q

Environmental causes/risks in PD

A

Exposure to herbicides/pesticides (inhibits complex 1), living in rural environment, consumption of well water, proximity to industrial plants or quarries, metal exposure, PCBs
-Smoking/caffeine associated with lower risk

33
Q

What does it mean to have a mutation in APP?

A

Causes increased amounts of Ab–>plaques, leads to familiar AD, just mutating APP doesn’t do much-have to wait a few years to see anything

34
Q

What does it mean to have a mutation in alpha-syn?

A

Genetic risk factor in PD, linked to familiar PD

35
Q

What does it mean to have a mutation in GBA?

A

Increases risk of familiar and sporadic PD, reduces PD age-of-onset and increases cognitive decline

36
Q

What does it mean to have a mutation in APOE?

A

Possibly halts AD? APOE4 is bad, APOE2 is a protective factor against AD

37
Q

Treatments for HD

A

No treatment to stop or reverse HD :(

-possibly could use tetrabenazine (prevents DA from entering vesicles, can’t be released)

38
Q

Treatments for AD

A

Cholinesterase inhibitors: slows breakdown of Ach by blocking the activity of acetylcholinesterase

39
Q

Treatments for PD

A

Levadopa, etc. (not really talked about in lecture but on slide)
-Apomorphine, dual pump, adenosine A2A receptor agonist, inosine, nilotinib, anti alpha-syn. antibodies

40
Q

Treating symptoms vs disease in HD

A

None for either, possibly tetrabenazine for symptoms, exercise helps

41
Q

Treating symptoms vs disease in AD

A

Cholinesterase inhibitors for symptoms, can’t cure AD

42
Q

Treating symptoms vs disease in PD

A

No cure for disease, can use deep-brain stimulation to STN or GPi to relieve symptoms (goal is to block overactivation of GPi/SNr)

43
Q

What type of system was used in hREST study?

A

Conditional expression system to overexpress hREST first in neural stem cells and later in striatal neurons that express the D2 receptor

44
Q

Why use conditional expression system in hREST study?

A

Constitutive REST overexpression model in mice is embryonically lethal

45
Q

Why are dopamine neurons more susceptible to MPTP?

A

MPP+ looks like DA, MPTP selectively targets DA in SN and inhibits complex 1 of mitochondria

46
Q

Evidence that there is decline in NGF transport with age in cholinergic neurons?

A

Decrease in NGF and TRKA receptor leads to increase in p75NTR which is linked to cell death, can also lead to increase in Ab
-decreased NGF receptors

47
Q

What causes expansion in HD?

A

Slippage in DNA polymerase

48
Q

Anticipation (HD)

A

Age of onset appears earlier (symptoms more severe too) as the disorder is passed from one generation to the next

49
Q

Gain of function features in Htt gene

A

Expanded polyQ enables protein to do something it normally couldn’t do

50
Q

Loss of function features in Htt gene

A

PolyQ prevents protein from doing what it normally does

51
Q

Cholinergic Hypothesis

A
  • Inability to obtain or use NGF underlies demise of CBF neurons
  • Basil forebrain cholinergic (CBF) cell death correlates with disease severity, pathology, and synapse loss
  • In AD
52
Q

What is APP good for? (4)

A
  1. Axonal transport
  2. Cell adhesion
  3. Cell growth
  4. Synaptic plasticity
53
Q

BACE inhibitor

A

Beta secretase inhibitor, reduces Ab production, KO has rescued memory defect in mice, in AD

54
Q

HDAC inhibitor

A

Preserves learning and memory performance in mice, restores “lost” memory in mice

55
Q

Synaptic NMDR

A

Activates CREB, stimulates BDNF, neuroprotective, more alpha-sec., less Ab

56
Q

Extrasynaptic NMDR

A

Decreased CREB, BDFN, dysregulate mitochondria, glutamate toxicity, less a-sec., increased Ab, increased BACE

57
Q

Where does glutamate enter in synaptic NMDR?

A

Glut released from vesicles

58
Q

Where does glutamate enter in extrasynaptic NMDR?

A

Activated by spillover glutamate at dendrite shaft, cell body

59
Q

Memantine/nitromemantine

A

Targets extrasynaptic NMDARs, decreased Ab levels

60
Q

Does Ab stimulate glutamate release and where? Synaptic or extrasynaptic?

A

Engages alpha-7 nicotinic acetylcholine receptors to release astrocytic glutamate–>extrasynaptic NMDA receptors on neurons

61
Q

What happens in post-synaptic neurons after glutamate is released?

A

Increases in calcium and nitric oxide, chronic Ab exposure in-vivo shows increased glu baseline current

62
Q

Does Abeta affect synaptic plasticity?

A

In hippocampus, eNMDAR activity is followed by reduction in evoked and miniature EPSCs

63
Q

What happens in spines after Ab activation of eNDMAR?

A

Greater presence of phosphorylated Tau, in-vivo synapse loss

64
Q

What gene does REST target?

A

DRD2, strong binding in striatal neurons

65
Q

Apomorphine (APO)

A

Dopamine receptor agonist that rescues loss of DA due to MPTP

66
Q

Point mutations causing accelerated aggregation of alpha-syn? (2)

A

A53T (more potent), A30P

67
Q

What do PINK1 and Parkin do?

A

Work together to induce mitophagy, mutations here cause issues

68
Q

What does LRRK2 do?

A

Important for synaptic vesicle formation, KO’s have fewer and smaller vesicle size with altered vesicular recycling

69
Q

How does L-DOPA work?

A

Prevents metabolism outside of the brain and increases efficiency/availability of L-DOPA crossing BBB

70
Q

Neuroprotective factors in PD (3)

A
  1. Nicotine
  2. BDNF treatment
  3. Exercise
71
Q

Do gut microbiomes effect locomotor behavior?

A

Alpha-syn. overexpression (ASO) without gut bacteria (GF), short-chain fatty acids seem to “mediate” PD gut-brain signaling

72
Q

What is the effect of gut microbiome on alpha-syn. pathology?

A

GF-ASO mice microglia look like Wt

73
Q

Are effects of gut microbiome something determined early in life or is it an active, lifelong communication?

A

Active, lifelong communication